These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7942381)

  • 21. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
    Kim T; Son C; Lee J; Kim K
    Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation in pigs of Nobi-Vac AR and an experimental atrophic rhinitis vaccine containing P multocida DNT-toxoid and B bronchiseptica.
    Kobisch M; Pennings A
    Vet Rec; 1989 Jan; 124(3):57-61. PubMed ID: 2919495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination against atrophic rhinitis in swine with a combined Bordetella bronchiseptica, Pasteurella multocida vaccine.
    Schuller W; Trubrich H; Kosztolich O; Flatscher J; Jahn J
    Zentralbl Veterinarmed B; 1980; 27(2):125-30. PubMed ID: 7467988
    [No Abstract]   [Full Text] [Related]  

  • 24. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
    PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D.
    Thurston JR; Rimler RB; Ackermann MR; Cheville NF
    Vet Immunol Immunopathol; 1992 Jun; 33(1-2):155-62. PubMed ID: 1632076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrophic rhinitis vaccine composition triggers different serological profiles that do not correlate with protection.
    Magyar T; Donkó T; Kovács F
    Acta Vet Hung; 2008 Mar; 56(1):27-40. PubMed ID: 18401954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
    Hur J; Byeon H; Lee JH
    Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Field evaluation of thirteen regimens for the control of progressive atrophic rhinitis.
    Pejsak Z; Wasińska B; Markowska-Daniel I; Hogg A
    Comp Immunol Microbiol Infect Dis; 1994 May; 17(2):125-32. PubMed ID: 7924245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal administration of Pasteurella multocida toxin in a challenge-exposure model used to induce subclinical signs of atrophic rhinitis in pigs.
    van Diemen PM; de Jong MF; de Vries Reilingh G; van der Hel P; Schrama JW
    Am J Vet Res; 1994 Jan; 55(1):49-54. PubMed ID: 8141495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vaccination of sows with Bordetella bronchiseptica on the incidence of atrophic rhinitis in swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1977 Sep; 29(9):369-75. PubMed ID: 905119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Possibilities for the establishment of pneumonia-free swine herds by immunization and administration of cefquinome].
    Schimmel D
    Berl Munch Tierarztl Wochenschr; 1992 Nov; 105(11):378-80. PubMed ID: 1471972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxigenic type A Pasteurella multocida as a causative agent of nasal turbinate atrophy in swine.
    Sakano T; Taneda A; Okada M; Ono M; Hayashi Y; Sato S
    J Vet Med Sci; 1992 Jun; 54(3):403-7. PubMed ID: 1386531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation into the pathogenesis of atrophic rhinitis in pigs. II. AR induction and protection after intramuscular injections cell-free filtrates and emulsions containing AR toxin of Pasteurella multocida.
    de Jong MF; de Wachter JC; vd Marel GM
    Vet Q; 1986 Jul; 8(3):215-24. PubMed ID: 3750803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of Pasteurella multocida dermonecrotic toxin-challenged rats by toxoid-induced antibody.
    Pettit RK; Rimler RB; Ackermann MR
    Vet Microbiol; 1993 Feb; 34(2):167-73. PubMed ID: 8451832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection by toxoid-induced antibody of gnotobiotic piglets challenged with the dermonecrotic toxin of Pasteurella multocida.
    Frymus T; Müller E; Franz B; Petzoldt K
    Zentralbl Veterinarmed B; 1989 Nov; 36(9):674-80. PubMed ID: 2532834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of EBL cells and ELISA in the culture and serological diagnosis of rhinitis atrophicans in swine].
    Alt M; Bechmann G; Schöss P
    Dtsch Tierarztl Wochenschr; 1993 Mar; 100(3):99-102. PubMed ID: 8472645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.